A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study will be the first evaluation of Symlin in adolescent subjects with type 1 diabetes
mellitus and is designed to evaluate the blood levels (pharmacokinetics), biochemical and
physiological effects (pharmacodynamics), and safety and tolerability of Symlin in these
subjects.